Close Menu

Raynard Kington, acting director of NIH, said last week that the agency had received more than 20,000 comments on its proposed stem cell guidelines and now the number of comments is thought to be even higher, reports Science Insider. One concern expressed in the comments sifted through thus far include that the ethical requirements of the draft guidelines will prohibit the use of many existing human embryonic stem cell lines, including the ones approved by the Bush Administration.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Wall Street Journal looks into FamilyTreeDNA's handling of genetic genealogy searches by law enforcement.

In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.

MIT's Technology Review reports that researchers hope to develop a CRISPR-based pain therapy.

In Science this week: atlas of malaria parasites' gene expression across their life cycles, and more.